Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, David J. Kuter|Blood Advances|2019Cited by 1.1k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, Alan Lichtin et al.|The Lancet|2008Cited by 862
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITPJames B. Bussel, Janet L. Nichol, David J. Kuter et al.|New England Journal of Medicine|2006Cited by 530
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopeniaJames B. Bussel, Joe McIntosh, David J. Kuter et al.|Blood|2014Cited by 162
Serum free light chain analysisMatthew S. Davids, David J. Kuter, Mandakolathur R. Murali|American Journal of Hematology|2010Cited by 107